Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer

Logan P Rhea¹, Brinda Gupta², Jeanny B Aragon-Ching^3
1 Department of Medicine, Inova Fairfax Medical Center, Fairfax, VA 22042, USA
² Department of Medicine, Virginia Commonwealth University, Richmond, VA 23219, USA
³ GU Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA 22031, USA

Correspondence Address:
Jeanny B Aragon-Ching
GU Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA 22031, USA

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/aja.aja_88_18